These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 2159564
1. v-mos protein produced by in vitro translation has protein kinase activity. Herzog NK, Nash M, Ramagli LS, Arlinghaus RB. J Virol; 1990 Jun; 64(6):3093-6. PubMed ID: 2159564 [Abstract] [Full Text] [Related]
2. v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant. Singh B, Stocking C, Walker R, Yang YD, Ostertag W, Arlinghaus RB. J Virol; 1992 Feb; 66(2):1267-72. PubMed ID: 1309903 [Abstract] [Full Text] [Related]
3. Use of antipeptide antibodies to probe the catalytic activity of p37v-mos. Singh B, al-Bagdadi F, Liu JX, Arlinghaus RB. Virology; 1990 Oct; 178(2):535-42. PubMed ID: 2171192 [Abstract] [Full Text] [Related]
4. Evidence for involvement of the protein kinase C pathway in the activation of p37v-mos protein kinase. al-Bagdadi F, Singh B, Arlinghaus RB. Oncogene; 1990 Aug; 5(8):1251-7. PubMed ID: 2168030 [Abstract] [Full Text] [Related]
6. A cAMP-independent serine/threonine kinase activity is associated with the mos sequences of ts110 Moloney murine sarcoma virus-encoded P85gag-mos. Maxwell SA, Arlinghaus RB. J Gen Virol; 1985 Oct; 66 ( Pt 10)():2135-46. PubMed ID: 2995551 [Abstract] [Full Text] [Related]
7. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell. Gerfaux J, Sergiescu D, Hamelin R, Joret AM, Lallemand C. Mol Carcinog; 1990 Oct; 3(2):103-13. PubMed ID: 2161237 [Abstract] [Full Text] [Related]
11. Functions of the mos oncogene family and associated gene products. Bold RJ, Hannink M, Donoghue DJ. Cancer Surv; 1986 Oct; 5(2):243-55. PubMed ID: 2946405 [Abstract] [Full Text] [Related]
15. Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation. Freeman RS, Donoghue DJ. Mol Cell Biol; 1989 Sep; 9(9):4087-90. PubMed ID: 2528689 [Abstract] [Full Text] [Related]
16. Human proto-oncogene c-mos maps to 8q11. Caubet JF, Mathieu-Mahul D, Bernheim A, Larsen CJ, Berger R. EMBO J; 1985 Sep; 4(9):2245-8. PubMed ID: 3000766 [Abstract] [Full Text] [Related]
17. The gag-mos hybrid protein of ts110 Moloney murine sarcoma virus: variation of gene expression with temperature. Gallick GE, Hamelin R, Maxwell S, Duyka D, Arlinghaus RB. Virology; 1984 Dec; 139(2):366-74. PubMed ID: 6097031 [Abstract] [Full Text] [Related]
18. Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene. Seth A, Vande Woude GF. J Virol; 1985 Oct; 56(1):144-52. PubMed ID: 2993645 [Abstract] [Full Text] [Related]
19. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon. Sergiescu D, Gerfaux J, Joret AM, Chany C. Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718 [Abstract] [Full Text] [Related]
20. The P55 protein affected by v-mos expression is vimentin. Singh B, Goldman R, Hutton L, Herzog NK, Arlinghaus RB. J Virol; 1987 Nov; 61(11):3625-9. PubMed ID: 2822968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]